Seal for Enhanced Stented Valve Fixation

• US 20070244544A1
• Filed: 04/14/2006
• Published: 10/18/2007
• Est. Priority Date: 04/14/2006
• Status: Abandoned Application

• Current Assignee: Medtronic Vascular, Inc. (Medtronic Plc)
• Original Assignee: Medtronic Vascular, Inc. (Medtronic Plc)
• Inventors: Goshgarian, Justin, Birdsall, Matthew, Krivoruchko, Michael, Dolan, Mark, Untereker, Darrel, Lessar, Joseph, Urbanski, Peter
• Application Number:
  US11/279,769
• Publication Number:
  US 20070244544A1
• Time in Patent Office: Days
• US Class Current: 623/1.260
• CPC Class Codes: A61F 2/2412 with soft flexible valve members, e.g. tissue valves shaped like natural valves check valves with flexible valve members in general F16K15/14
• CPC Class Codes: A61F 2/2418 Scaffolds therefor, e.g. support stents
• CPC Class Codes: A61F 2/2433 using balloon catheter
• CPC Class Codes: A61F 2002/9528 for retrieval of stents
• CPC Class Codes: A61F 2210/0061 swellable
• CPC Class Codes: A61F 2250/006 modular
• CPC Class Codes: A61F 2250/0069 Sealing means
• CPC Class Codes: A61L 24/0031 Hydrogels or hydrocolloids
• CPC Class Codes: A61L 24/08 Polysaccharides A61L24/043 takes precedence
• CPC Class Codes: C08L 5/08 Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof

Abstract

A valve replacement system that can be used for treating abnormalities of the right ventricular outflow tract includes a prosthetic valve device having a sealant contacting at least a portion of the outer surface of the valve device. The sealant may be breakable, and may be a hydrogel, an expandable hydrogel, or a solid. One embodiment of the invention includes a flowable sealant that is injected within the vascular system. Another embodiment of the invention includes a method for replacing a pulmonary valve that includes forming a seal around the exterior surface of a replacement valve and preventing blood flow around the replacement valve.

Claims

1. A vascular valve replacement system, the system comprising:

a conduit having a lumen;

a catheter;

a prosthetic valve device including a valve connected to an expandable support structure, the valve device disposed on the catheter; and

a sealant disposed about an outer surface of the support structure of the valve device wherein when the prosthetic valve device is deployed from the catheter within the lumen of the conduit and the support structure is expanded, the sealant prevents blood flow between the conduit and the outer surface of the support structure of the valve device.

2. The system of claim 1 wherein the sealant is a hydrogel.

3. The system of claim 2 wherein the hydrogel comprises a biocompatible, nonthrombogenic polymer or copolymer composition in an aqueous medium.

4. The system of claim 3 wherein the polymer composition comprises polymers or copolymers that are cross-linked using a cross-linking agent.

5. The system of claim 4 wherein the polymer is alginate and the cross-linking agent is a divalent cation.

6. The system of claim 5 wherein the cross-linked alginate forms a breakable seal that prevents fibrosis about the exterior surface of the support structure and thereby facilitates removal of the valve device.

7. The system of claim 3 wherein the polymer composition is capable of hydration and dehydration.

8. The system of claim 7 wherein the volume of the hydrogel increases upon hydration of the polymer composition.

9. A pulmonary valve replacement system, the system comprising:

a conduit having an interior wall forming a lumen;

a prosthetic valve device including a valve connected to a support structure, the valve device positionable in the lumen of the conduit, and

a sealant composition disposed about at least a portion of the outer surface of the support structure, wherein the sealant composition is deployed in a flowable form via a catheter to prevent blood flow between the interior wall of the conduit and the outer surface of the support structure of the valve device.

10. The system of claim 9 wherein the sealant composition forms a hydrogel within the lumen of the conduit.

11. The system of claim 10 wherein the sealant composition comprises at least one polymer or copolymer and a cross-linking agent wherein when the polymer or copolymer is mixed with the cross-linking agent the composition forms a hydrogel.

12. The system of claim 9 wherein the sealant composition becomes a solid within the lumen of the conduit.

13. The system of claim 12 wherein the sealant composition comprises at least one polymer or copolymer that precipitates upon exposure to biological fluids.

14. A pulmonary valve replacement system, the system comprising:

a catheter;

a prosthetic valve device including a valve connected to an expandable support structure, the valve device disposed on the catheter;

an expandable molding device disposed on the catheter, the molding device including spaced-apart, distal and proximal seal portions and an interior mold portion positioned between the distal and proximal seal portions, and

a moldable sealant positioned within a space between an outer surface of the mold portions and an interior conduit wall to form a symmetrical molded lumen to receive the valve device.

15. The system of claim 14 wherein in a solid state, the moldable sealant exerts uniform pressure on all areas of the exterior surface of the support structure and maintains the prosthetic valve device in a fixed position that is perpendicular to the direction of blood flow within a vascular conduit.

16. The system of claim 15 wherein, in the solid state, the moldable sealant forms a seal and prevents blood flow around the support structure.

17. A method for replacing a valve, the method comprising:

delivering a prosthetic valve device including a valve connected to a support structure having a sealant disposed about at least a portion of the outer surface of the support structure to a treatment site within a conduit via catheter;

deploying the prosthetic valve device from the catheter;

positioning the prosthetic valve device within a conduit;

forming a seal; and

thereby preventing blood flow around the support structure via the sealant.

18. The method of claim 17 wherein forming a seal further comprises cross-linking at least one polymer or copolymer in an aqueous solution and forming a hydrogel in situ within the conduit.

19. The method of claim 17 wherein forming a seal further comprises precipitating at least one polymer or copolymer upon exposure to biological fluids within the conduit.

20. The method of claim 17 wherein forming a seal further comprises increasing the volume of a hydrogel by hydrating the polymer composition comprising the hydrogel and thereby increasing the volume of the hydrogel.

21. The method of claim 17 wherein forming a seal further comprises expressing a flowable composition from the catheter adjacent to the exterior surface of the support structure at the treatment site within the conduit and thereby preventing blood flow around the support structure via the flowable composition.

22. The method of claim 21 wherein forming a seal further comprises

molding the flowable composition so that it forms a mass that adheres to the vessel wall and has a uniform circular inner surface complementary to the exterior surface of the support structure;

solidifying the flowable composition;

deploying the prosthetic valve and support structure from the catheter;

inserting the prosthetic valve and support structure into mass of the solidified composition;

forming a seal around the support structure and valve; and

maintaining the prosthetic valve in a fixed position that is perpendicular to the direction of blood flow within the vascular conduit.

23. The method of claim 17 wherein replacing a pulmonary valve further comprises removing a defective prosthetic valve connected to the support structure by breaking a breakable seal disposed about the exterior surface of the support structure and removing the defective valve and support structure via catheter.